Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug ...

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 72.5% so far this year compared with an increase of 17.9% for ...

A US court has hit Teva where it hurts, invalidating four US patents on its latest version of multiple sclerosis drug, Copaxone. Mylan wants to market a cheaper version of Teva’s three-times a ...

Teva is poised to benefit from rising demand for generic drugs due to a favorable macro and political environment. Learn more ...

Teva Pharmaceutical Industries Ltd. is set to be hit with an antitrust fine from the European Union over allegations it tried ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone. The ...

Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

TEVA) and Viatris (NASDAQ:VTRS) have reportedly won a new chance to challenge patent covering Johnson and Johnson's (NYSE:JNJ ...

The announcement followed news that the Maryland city reached an $80 million settlement over opioids with Teva. Baltimore did ...

Stay informed and make strategic decisions with our Ratings Table. Teva Pharmaceutical Industries, based in Israel, is the ...

Major drug company Teva will pay Baltimore City $80 million to settle claims that it helped fuel the city's opioid crisis.